The treatment of osteosarcoma of the extremities: twenty year's experience at the Istituto Ortopedico Rizzoli

scientific article published on October 1981

The treatment of osteosarcoma of the extremities: twenty year's experience at the Istituto Ortopedico Rizzoli is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/1097-0142(19811001)48:7<1569::AID-CNCR2820480717>3.0.CO;2-X
P698PubMed publication ID6945143

P2093author name stringBertoni F
Franceschi C
Picci P
Campanacci M
Bacci G
Minutillo A
P2860cites workIrradiation of the lungs as an adjuvant therapy in the treatment of osteosarcoma of the limbs. An E.O.R.T.C. randomized studyQ41403761
P433issue7
P407language of work or nameEnglishQ1860
P304page(s)1569-1581
P577publication date1981-10-01
P1433published inCancerQ326041
P1476titleThe treatment of osteosarcoma of the extremities: twenty year's experience at the Istituto Ortopedico Rizzoli
P478volume48

Reverse relations

cites work (P2860)
Q66812375A humeral modular prostheses for bone tumour surgery: a study of 56 cases
Q40179159A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma.
Q56996677Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients
Q94322242Chemotherapy for treating high‐grade osteosarcoma in children and young adults
Q47360357Current and future therapeutic approaches for osteosarcoma.
Q37265109Current status and perspectives regarding the treatment of osteo-sarcoma: chemotherapy
Q38161735Current therapeutic strategies and novel approaches in osteosarcoma
Q34307165Current treatment of high grade osteosarcoma of the extremity: review
Q50856812Evaluation of HLA-DR expression and T-lymphocyte infiltration in osteosarcoma.
Q27307103Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice
Q50861517Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy.
Q38219831Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma
Q40830532Historical, current and future aspects of osteosarcoma treatment
Q37782098How can survival be improved in localized osteosarcoma?
Q33557868Inhibition of tumors cell growth in osteosarcoma-bearing SD rats through a combination of conventional and metronomic scheduling of neoadjuvant chemotherapy
Q70906953Intracortical osteosarcoma: rare entity or early manifestation of classical osteosarcoma?
Q67923500Isolation perfusion of the lower limb with platinum
Q78029619Letter to the editor: osteogenic sarcoma--cutaneous metastases
Q41613919Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy.
Q34588488Long-term survivals of stage IIb osteosarcoma: a 20-year experience in a single institution
Q72027269Magnetic resonance relaxation times of normal tissue in the course of chemotherapy: a study in patients with bone sarcoma
Q44459385Malignant fibrous histiocytoma of bone the experience at the Rizzoli Institute: Report of 90 cases
Q74751280Malignant tumors of the osteogenic matrix
Q37941806Management of canine appendicular osteosarcoma
Q73837751Massive bone allografts in the treatment of pathologic fractures due to bone metastases
Q30881881National Cancer Data Base report on osteosarcoma of the head and neck.
Q32100844Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol
Q36490672Nuclear polymorphism in osteosarcomas as a prognostic factor for the effect of chemotherapy. A quantitative study
Q41704948On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy
Q36743183Osteosarcoma: then and now. A fifty year review at Royal Prince Alfred Hospital
Q40169054Pain in the Cancer Patient as a Consequence of Therapy (Surgery, Radiotherapy, Chemotherapy)
Q57008525Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy
Q43754201Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute
Q35921352Present-day concepts in the management of sarcomas in children
Q36803705Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison
Q34135065Proteins expressed in osteosarcoma and serum levels as prognostic factors
Q36731426Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
Q73702556Serum antibodies against the heat shock protein 60 are elevated in patients with osteosarcoma
Q67726432Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience
Q38232992Systematic review of high-dose and standard-dose chemotherapies in the treatment of primary well-differentiated osteosarcoma
Q33279107Telomerase activity in skeletal sarcomas
Q35858388The efficacy of high-dose versus moderate-dose chemotherapy in treating osteosarcoma: a systematic review and meta-analysis
Q70929821The pathologist's role in the diagnosis and treatment of osteosarcoma in children
Q37409192Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma
Q40387200Treatment recommendations for osteosarcoma and adult soft tissue sarcomas
Q38520992Trends and variability in survival among patients with osteosarcoma: a 7-year update
Q57000995Twenty-year follow-up of osteosarcoma of the extremity treated with adjuvant chemotherapy
Q34161337What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
Q69817164[New morphologic findings in malignant bone tumors]

Search more.